Background
Methods
Subjects
R-R interval power spectral analysis
Statistical analysis
Results
Smokers | Non-smokers |
P value
| |
---|---|---|---|
Number | 38 | 32 | |
Sex | 7/31 | 11/21 | |
Age (years) | 57.9 ± 12.5 | 54.3 ± 13.6 | 0.241 |
Duration of illness | 33.2 ± 14.5 | 32.7 ± 13.5 | 0.876 |
ln total1
| 4.5 ± 1.2 | 3.9 ± 1.2 | 0.071 |
ln LF1
| 3.8 ± 1.3 | 3.2 ± 1.4 | 0.163 |
ln HF1
| 3.8 ± 1.2 | 3.1 ± 1.3 | 0.016*
|
BMI (kg/m2) | 22.7 ± 4.0 | 21.7 ± 4.0 | 0.276 |
ALB (g/dL) | 4.0 ± 0.3 | 4.0 ± 0.4 | 0.204 |
BS (mg/dL) | 89.7 ± 17.4 | 87.5 ± 15.5 | 0.655 |
LDL-C (mg/dL) | 119.0 ± 33.2 | 108.4 ± 29.6 | 0.163 |
TC (mg/dL) | 200.4 ± 42.2 | 183.9 ± 32.0 | 0.065 |
TG (mg/dL) | 118.9 ± 91.1 | 86.0 ± 43.2 | 0.073 |
HDL-C (mg/dL) | 60.4 ± 16.6 | 55.9 ± 13.2 | 0.222 |
CPZeq*2 (mg) | 1229 ± 750 | 1162 ± 792 | 0.717 |
BPDeq*2 (mg) | 2.9 ± 1.9 | 1.6 ± 1.6 | 0.003*
|
DZPeq*2 (mg) | 10.1 ± 6.9 | 9.3 ± 7.4 | 0.653 |
GAF score | 28.9 ± 3.1 | 29.2 ± 2.2 | 0.682 |
Smokers | Non-smokers | ||||||||
---|---|---|---|---|---|---|---|---|---|
n = 38 |
n = 32 | ||||||||
Baseline | Three years | Changes |
p
| Baseline | Three years | Changes |
P
|
Comparison
| |
ln total1
| 4.5 ± 1.2 | 4.0 ± 1.7 | −0.50 ± 1.57 | 0.061 | 3.9 ± 1.2 | 3.9 ± 1.4 | −0.11 ± 0.95 | 0.681 | 0.218 |
ln LF1
| 3.8 ± 1.3 | 3.0 ± 1.8 | −0.79 ± 1.73 | 0.049*
| 3.2 ± 1.4 | 3.2 ± 1.5 | −0.09 ± 0.96 | 0.715 | 0.133 |
ln HF1
| 3.8 ± 1.2 | 3.4 ± 1.7 | −0.44 ± 1.67 | 0.136 | 3.1 ± 1.3 | 3.1 ± 1.5 | −0.85 ± 1.17 | 0.915 | 0.304 |
BMI (kg/m2) | 22.7 ± 4.0 | 21.1 ± 3.6 | −1.56 ± 3.64 | 0.020*
| 21.7 ± 4.0 | 20.8 ± 3.9 | −0.92 ± 2.17 | 0.022*
| 0.373 |
ALB (g/dL) | 4.0 ± 0.3 | 3.9 ± 0.4 | −0.03 ± 0.38 | 0.564 | 4.0 ± 0.4 | 3.9 ± 0.4 | −0.15 ± 0.46 | 0.076 | 0.240 |
BS (mg/dL) | 89.7 ± 17.4 | 87.6 ± 14.6 | −1.7 ± 18.6 | 0.568 | 87.5 ± 15.5 | 87.7 ± 14.1 | 0.16 ± 16.2 | 0.957 | 0.654 |
LDL-C (mg/dL) | 119.0 ± 33.2 | 115.6 ± 36.2 | −2.3 ± 39.0 | 0.717 | 108.4 ± 29.6 | 110.2 ± 27.3 | 1.7 ± 29.2 | 0.740 | 0.631 |
TC (mg/dL) | 200.4 ± 42.2 | 190.4 ± 42.2 | −10.4 ± 52.1 | 0.291 | 183.9 ± 32.0 | 186.3 ± 35.1 | 2.4 ± 27.2 | 0.620 | 0.421 |
TG (mg/dL) | 118.9 ± 91.1 | 100.0 ± 48.0 | −18.9 ± 93.1 | 0.212 | 86.0 ± 43.2 | 96.1 ± 40.8 | 10.2 ± 46.2 | 0.223 | 0.096 |
HDL-C (mg/dL) | 60.4 ± 16.6 | 70.3 ± 18.0 | 9.92 ± 18.2 | 0.002*
| 55.9 ± 13.2 | 64.0 ± 18.9 | 8.1 ± 13.5 | 0.002*
| 0.635 |
CPZeq2 (mg) | 1229 ± 750 | 1008 ± 646 | −221 ± 576 | 0.031*
| 1162 ± 792 | 1075 ± 810 | −86.7 ± 489 | 0.323 | 0.302 |
BPDeq2 (mg) | 2.9 ± 1.9 | 2.3 ± 1.7 | −0.63 ± 1.7 | 0.018*
| 1.6 ± 1.6 | 1.7 ± 1.7 | 0.15 ± 1.8 | 0.623 | 0.061 |
DZPeq2 (mg) | 10.1 ± 6.9 | 8.6 ± 6.9 | −1.5 ± 6.4 | 0.190 | 9.3 ± 7.4 | 9.1 ± 7.4 | −0.12 ± 6.6 | 0.914 | 0.379 |
GAF score | 28.9 ± 3.1 | 27.9 ± 4.1 | −1.1 ± 3.1 | 0.444 | 29.2 ± 2.2 | 29.4 ± 2.1 | 0.15 ± 1.5 | 0.572 | 0.040*
|